Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Disopyramide 250mg modified-release tablets
0203020G0AAACAC
|
Disopyramide phosphate | Disopyramide phosphate | Cardiovascular System | 1,206 |
|
Rythmodan Retard 250mg tablets
0203020G0BDABAC
|
Rythmodan (Injection/Tablet) | Disopyramide phosphate | Cardiovascular System | 217 |
|
Dirythmin SA 150mg tablets
0203020G0BCABAE
|
Dirythmin | Disopyramide phosphate | Cardiovascular System | No data available |
|
Disopyramide 150mg modified-release tablets
0203020G0AAAEAE
|
Disopyramide phosphate | Disopyramide phosphate | Cardiovascular System | No data available |
|
Disopyramide 250mg modified-release capsules
0203020G0AAABAB
|
Disopyramide phosphate | Disopyramide phosphate | Cardiovascular System | No data available |
|
Disopyramide 50mg/5ml solution for injection ampoules
0203020G0AAAFAF
|
Disopyramide phosphate | Disopyramide phosphate | Cardiovascular System | No data available |
|
Isomide CR 250mg capsules
0203020G0BBAAAB
|
Isomide CR | Disopyramide phosphate | Cardiovascular System | No data available |
|
Rythmodan 50mg/5ml solution for injection ampoules
0203020G0BDAAAF
|
Rythmodan (Injection/Tablet) | Disopyramide phosphate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.